Driven by our commitment to care

Since taking on the role of CEO of AdhereTech in January 2020, Chris O’Brien’s vision and leadership have enabled the company to scale and form partnerships with many of the world’s top pharmaceutical manufacturers. He is motivated by a desire to use new technologies to resolve longstanding disparities in the healthcare system. Chris focuses the AdhereTech team on long-term investment, product development and solutions that have helped deploy the company’s Aidia System to a growing number of patients. He began working in healthcare in 2012 when he joined digital health company Everyday Health (acquired by Ziff Davis), expanding the company’s audience to 800,000 physicians, growing its revenue and creating the industry’s first native advertising platform. Prior to that Chris founded and ran a number of venture-backed technology companies, the most recent of which was acquired by HP in 2010. Chris holds a BA degree in Mathematics and Philosophy from Brown University.

Gregory Gallo serves as Chief Revenue Officer at AdhereTech. In his role, he leads the company’s commercial-facing activities for AdhereTech’s core products and new innovations. Greg brings more than 25 years’ experience helping life science and digital health businesses launch, scale and go to market, from early-stage startups to global enterprises. Prior to AdhereTech, Greg helped launch and grow a number of companies, including Quest Diagnostics Informatics, Impact Rx, Activate Networks, Treato, Medifind and Vidence – all companies leveraging innovative data and analytics to improve brand and salesforce effectiveness, patient treatment and outcomes or extend new healthcare services to patients. He started his career at Johnson & Johnson and Quest Diagnostics in sales leadership. Greg earned his BA degree from the College of New Jersey and completed multiple courses in sales force management, marketing, finance and accounting at The Wharton School’s Executive Education Program at the University of Pennsylvania.

Jeremy Gilbert is Chief Product Development Officer for AdhereTech. He joined the company in 2021, bringing extensive leadership expertise spanning the healthcare industry. At AdhereTech, Jeremy leads the teams that drive the lifecycle of new products including conception, design, technical development, go-to-market strategy, and launch. Jeremy previously drove product and technology for health technology companies in his roles as Chief Product Officer for Pear Therapeutics and as Vice President of Product and Strategy for PatientsLikeMe. Jeremy holds a BA in Computer Science from Brandeis University, as well as an MBA from the MIT Sloan School of Management.

John Langhauser is the technical cofounder and former Chief Technology Officer at AdhereTech. In his current role as Chief Operating Officer, he partners with senior leaders to ensure that the patient-first, customer-first ideals AdhereTech was founded upon continue to be reflected in every product launch, patient interaction and customer experience. As cofounder, John was directly responsible for early software and product development, strategic product roadmapping and corporate governance. Throughout the growth of AdhereTech, he has focused on product development, process improvement, and quality control. Prior to cofounding AdhereTech in 2012 John was a software engineer at Bridgewater Associates. John holds an MS in Computer Science and a BS in Electrical Engineering and Computer Science from Yale.

Josh Stein cofounded AdhereTech in 2011, providing the vision and business acumen to turn an idea into a thriving healthcare technology business that improves patients’ lives, and spans the complex markets of healthcare, software, enterprise sales, hardware IoT, data analysis and clinical research. As founding CEO from 2011-2019, Josh led all aspects of the business as AdhereTech built long-term partnerships with pharmaceutical and healthcare companies, investors, and patients. His team-building skills and dedication to creating better health outcomes have led to improved medication adherence for tens of thousands of people every day with the Aidia System. Josh earned his MBA from the Wharton School of Business and a BA from Washington University in St. Louis.